Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Good

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
Infection and Immunity|February 24, 2016
Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria InfectionJessica R Loughland, Gabriela Minigo, Julie Burel, et al.
Clinical & Translational Immunology|September 16, 2021
Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super-infectionMehfuz Zaman, Victor C Huber, Dustin L Heiden, et al.
The Journal of Clinical Investigation|July 19, 2013
Cross-species malaria immunity induced by chemically attenuated parasitesMichael F Good, Jennifer M Reiman, I Bibiana Rodriguez, et al.
NPJ Vaccines|August 18, 2020
M-protein based vaccine induces immunogenicity and protection from <i>Streptococcus pyogenes</i> when delivered on a high-density microarray patch (HD-MAP)Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, et al.
NPJ Vaccines|September 18, 2020
Erratum: Author Correction: M-protein based vaccine induces immunogenicity and protection from <i>Streptococcus pyogenes</i> when delivered on a high-density microarray patch (HD-MAP)Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, et al.
Infection and Immunity|March 22, 2017
Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c<sup>+</sup> Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell ActivationTonia Woodberry, Jessica R Loughland, Gabriela Minigo, et al.
Lancet (London, England)|September 21, 2002
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparumDavid J Pombo, Gregor Lawrence, Chakrit Hirunpetcharat, et al.
Cell Host & Microbe|May 14, 2021
Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosisHanan A Al-Nazal, Emily Cooper, Mei Fong Ho, et al.
BMC Medicine|October 9, 2018
Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot studyDanielle I Stanisic, James Fink, Johanna Mayer, et al.
Malaria Journal|April 19, 2015
Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccinesDanielle I Stanisic, Xue Q Liu, Sai Lata De, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
Infection and Immunity|February 24, 2016
Profoundly Reduced CD1c+ Myeloid Dendritic Cell HLA-DR and CD86 Expression and Increased Tumor Necrosis Factor Production in Experimental Human Blood-Stage Malaria InfectionJessica R Loughland, Gabriela Minigo, Julie Burel, et al.
Clinical & Translational Immunology|September 16, 2021
Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super-infectionMehfuz Zaman, Victor C Huber, Dustin L Heiden, et al.
The Journal of Clinical Investigation|July 19, 2013
Cross-species malaria immunity induced by chemically attenuated parasitesMichael F Good, Jennifer M Reiman, I Bibiana Rodriguez, et al.
NPJ Vaccines|August 18, 2020
M-protein based vaccine induces immunogenicity and protection from <i>Streptococcus pyogenes</i> when delivered on a high-density microarray patch (HD-MAP)Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, et al.
NPJ Vaccines|September 18, 2020
Erratum: Author Correction: M-protein based vaccine induces immunogenicity and protection from <i>Streptococcus pyogenes</i> when delivered on a high-density microarray patch (HD-MAP)Jamie-Lee S Mills, Cesar M Jayashi Flores, Simone Reynolds, et al.
Infection and Immunity|March 22, 2017
Early Immune Regulatory Changes in a Primary Controlled Human Plasmodium vivax Infection: CD1c<sup>+</sup> Myeloid Dendritic Cell Maturation Arrest, Induction of the Kynurenine Pathway, and Regulatory T Cell ActivationTonia Woodberry, Jessica R Loughland, Gabriela Minigo, et al.
Lancet (London, England)|September 21, 2002
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparumDavid J Pombo, Gregor Lawrence, Chakrit Hirunpetcharat, et al.
Cell Host & Microbe|May 14, 2021
Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosisHanan A Al-Nazal, Emily Cooper, Mei Fong Ho, et al.
BMC Medicine|October 9, 2018
Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot studyDanielle I Stanisic, James Fink, Johanna Mayer, et al.
Malaria Journal|April 19, 2015
Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccinesDanielle I Stanisic, Xue Q Liu, Sai Lata De, et al.
Pageof 22